A citation-based method for searching scientific literature

Rik Derynck, Shannon J Turley, Rosemary J Akhurst. Nat Rev Clin Oncol 2021
Times Cited: 109







List of co-cited articles
1128 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Transforming Growth Factor-β Signaling in Immunity and Cancer.
Eduard Batlle, Joan Massagué. Immunity 2019
599
32

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, Yulei Wang, Edward E Kadel, Hartmut Koeppen, Jillian L Astarita, Rafael Cubas,[...]. Nature 2018
25

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.
Daniele V F Tauriello, Sergio Palomo-Ponce, Diana Stork, Antonio Berenguer-Llergo, Jordi Badia-Ramentol, Mar Iglesias, Marta Sevillano, Sales Ibiza, Adrià Cañellas, Xavier Hernando-Momblona,[...]. Nature 2018
782
18

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β.
Yan Lan, Dong Zhang, Chunxiao Xu, Kenneth W Hance, Bo Marelli, Jin Qi, Huakui Yu, Guozhong Qin, Aroop Sircar, Vivian M Hernández,[...]. Sci Transl Med 2018
235
15

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
14


Targeting TGF-β Signaling in Cancer.
Selcuk Colak, Peter Ten Dijke. Trends Cancer 2017
395
13

Contextual determinants of TGFβ action in development, immunity and cancer.
Charles J David, Joan Massagué. Nat Rev Mol Cell Biol 2018
314
12

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.
Rajani Ravi, Kimberly A Noonan, Vui Pham, Rishi Bedi, Alex Zhavoronkov, Ivan V Ozerov, Eugene Makarev, Artem V Artemov, Piotr T Wysocki, Ranee Mehra,[...]. Nat Commun 2018
133
12

TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.
Masato Morikawa, Rik Derynck, Kohei Miyazono. Cold Spring Harb Perspect Biol 2016
468
12

TGFbeta in Cancer.
Joan Massagué. Cell 2008
11

Signaling Receptors for TGF-β Family Members.
Carl-Henrik Heldin, Aristidis Moustakas. Cold Spring Harb Perspect Biol 2016
271
11

TGFβ signalling in context.
Joan Massagué. Nat Rev Mol Cell Biol 2012
10

Latent TGF-β structure and activation.
Minlong Shi, Jianghai Zhu, Rui Wang, Xing Chen, Lizhi Mi, Thomas Walz, Timothy A Springer. Nature 2011
582
10

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
E Dodagatta-Marri, D S Meyer, M Q Reeves, R Paniagua, M D To, M Binnewies, M L Broz, H Mori, D Wu, M Adoumie,[...]. J Immunother Cancer 2019
68
14

Non-Smad Signaling Pathways of the TGF-β Family.
Ying E Zhang. Cold Spring Harb Perspect Biol 2017
321
10

A framework for advancing our understanding of cancer-associated fibroblasts.
Erik Sahai, Igor Astsaturov, Edna Cukierman, David G DeNardo, Mikala Egeblad, Ronald M Evans, Douglas Fearon, Florian R Greten, Sunil R Hingorani, Tony Hunter,[...]. Nat Rev Cancer 2020
699
10

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
10

TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure.
Ankur Chakravarthy, Lubaba Khan, Nathan Peter Bensler, Pinaki Bose, Daniel D De Carvalho. Nat Commun 2018
178
9

Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins.
Ian B Robertson, Daniel B Rifkin. Cold Spring Harb Perspect Biol 2016
172
9

Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.
Constance J Martin, Abhishek Datta, Christopher Littlefield, Ashish Kalra, Christopher Chapron, Stefan Wawersik, Kevin B Dagbay, Christopher T Brueckner, Anastasia Nikiforov, Francis T Danehy,[...]. Sci Transl Med 2020
70
12

TGF-β Signaling from Receptors to Smads.
Akiko Hata, Ye-Guang Chen. Cold Spring Harb Perspect Biol 2016
332
9

Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma.
John C Morris, Antoinette R Tan, Thomas E Olencki, Geoffrey I Shapiro, Bruce J Dezube, Michael Reiss, Frank J Hsu, Jay A Berzofsky, Donald P Lawrence. PLoS One 2014
233
9

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.
Alexandre Calon, Enza Lonardo, Antonio Berenguer-Llergo, Elisa Espinet, Xavier Hernando-Momblona, Mar Iglesias, Marta Sevillano, Sergio Palomo-Ponce, Daniele V F Tauriello, Daniel Byrom,[...]. Nat Genet 2015
614
8



TGF-β Family Signaling in the Control of Cell Proliferation and Survival.
Yun Zhang, Peter B Alexander, Xiao-Fan Wang. Cold Spring Harb Perspect Biol 2017
184
8

Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells.
Naoki Takasaka, Robert I Seed, Anthony Cormier, Andrew J Bondesson, Jianlong Lou, Ahmed Elattma, Saburo Ito, Haruhiko Yanagisawa, Mitsuo Hashimoto, Royce Ma,[...]. JCI Insight 2018
54
14

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors.
Julius Strauss, Christopher R Heery, Jeffrey Schlom, Ravi A Madan, Liang Cao, Zhigang Kang, Elizabeth Lamping, Jennifer L Marté, Renee N Donahue, Italia Grenga,[...]. Clin Cancer Res 2018
191
8



Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances.
Hanne Lind, Sofia R Gameiro, Caroline Jochems, Renee N Donahue, Julius Strauss, James L Gulley, Claudia Palena, Jeffrey Schlom. J Immunother Cancer 2020
86
9

Targeting TGFβ signal transduction for cancer therapy.
Sijia Liu, Jiang Ren, Peter Ten Dijke. Signal Transduct Target Ther 2021
59
13

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.
Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A Wargo, Antoni Ribas. Cell 2017
8

Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells.
Shun Li, Ming Liu, Mytrang H Do, Chun Chou, Efstathios G Stamatiades, Briana G Nixon, Wei Shi, Xian Zhang, Peng Li, Shengyu Gao,[...]. Nature 2020
65
10

TGF-β suppresses type 2 immunity to cancer.
Ming Liu, Fengshen Kuo, Kristelle J Capistrano, Davina Kang, Briana G Nixon, Wei Shi, Chun Chou, Mytrang H Do, Efstathios G Stamatiades, Shengyu Gao,[...]. Nature 2020
52
13

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
WanJun Chen, Wenwen Jin, Neil Hardegen, Ke-Jian Lei, Li Li, Nancy Marinos, George McGrady, Sharon M Wahl. J Exp Med 2003
7

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.
Silvia C Formenti, Percy Lee, Sylvia Adams, Judith D Goldberg, Xiaochun Li, Mike W Xie, Josephine A Ratikan, Carol Felix, Lin Hwang, Kym F Faull,[...]. Clin Cancer Res 2018
123
7

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
Zvi G Fridlender, Jing Sun, Samuel Kim, Veena Kapoor, Guanjun Cheng, Leona Ling, G Scott Worthen, Steven M Albelda. Cancer Cell 2009
7

TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors.
Na Tang, Chen Cheng, Xingying Zhang, Miaomiao Qiao, Na Li, Wei Mu, Xiao-Fei Wei, Weidong Han, Haoyi Wang. JCI Insight 2020
90
7

Induction of heart valve lesions by small-molecule ALK5 inhibitors.
Mark J Anderton, Howard R Mellor, Alex Bell, Claire Sadler, Martin Pass, Steve Powell, Samantha J Steele, Ruth R A Roberts, Annabelle Heier. Toxicol Pathol 2011
157
7

Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
7

Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
Julie Stockis, Stéphanie Liénart, Didier Colau, Amandine Collignon, Stephen L Nishimura, Dean Sheppard, Pierre G Coulie, Sophie Lucas. Proc Natl Acad Sci U S A 2017
53
13

TGF-β activation and function in immunity.
Mark A Travis, Dean Sheppard. Annu Rev Immunol 2014
433
7

TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.
Claire Vanpouille-Box, Julie M Diamond, Karsten A Pilones, Jiri Zavadil, James S Babb, Silvia C Formenti, Mary Helen Barcellos-Hoff, Sandra Demaria. Cancer Res 2015
301
7


A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment.
Linh Khanh Huynh, Christopher John Hipolito, Peter Ten Dijke. Biomolecules 2019
69
8

A Potent Pan-TGFβ Neutralizing Monoclonal Antibody Elicits Cardiovascular Toxicity in Mice and Cynomolgus Monkeys.
Mayur S Mitra, Karla Lancaster, Adeyemi O Adedeji, Gopinath S Palanisamy, Rutwij A Dave, Fiona Zhong, Matthew S Holdren, Shannon J Turley, Wei-Ching Liang, Yan Wu,[...]. Toxicol Sci 2020
27
22

Turning foes to friends: targeting cancer-associated fibroblasts.
Xueman Chen, Erwei Song. Nat Rev Drug Discov 2019
461
6

TGF-β: the master regulator of fibrosis.
Xiao-Ming Meng, David J Nikolic-Paterson, Hui Yao Lan. Nat Rev Nephrol 2016
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.